Venus Remedies (NSE:VENUSREM) Moat Score: 0/10 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:VENUSREM Venus Remedies Ltd NSE:VENUSREM
58 GF Score
Price ₹1,775.50
GF Value ₹512.09
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Venus Remedies Moat Score?

Venus Remedies has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Venus Remedies has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Venus Remedies might have No Moat - No discernible moat.

Venus Remedies  (NSE:VENUSREM) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Venus Remedies Moat Score Related Terms

NSE:VENUSREM
58GF Score
Venus Remedies Ltd NSE:VENUSREM
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Venus Remedies (NSE:VENUSREM) Overvalued in 2026?

Based on GuruFocus' analysis, Venus Remedies stock appears to be overvalued. The current stock price of ₹1,775.50 is trading 246.7% above its estimated GF Value™ of ₹512.09. GuruFocus considers Venus Remedies to be Significantly Overvalued.

Key valuation signals for NSE:VENUSREM:

  • Moat Score: 0
  • GF Value™: ₹512.09 vs. price of ₹1,775.50 (246.7% above fair value)
  • GF Score™: 58/100 with 6 warning signs

No single metric tells the full story. See the NSE:VENUSREM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Venus Remedies Business Description

Other Exchanges 526953:India
Address Plot 51-52, Industrial Area, Phase 1, Panchkula, HR, IND, 134113
Venus Remedies Ltd is an Indian drug manufacturer. It is engaged in manufacturing and trading pharmaceutical products. The company produces biologically active food supplements which include food supplements are natural complexes containing minerals, vitamins, dietary fibers, extracts of medicinal herbs, amino acids and others.
58GF Score

Get the complete analysis for NSE:VENUSREM

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,775.50
Price
₹512.09
GF Value